It is a trading private limited company based in Bangalore, Karnataka, India, established in 2016.
2016 | Bangalore, Karnataka, India | ActiveEpikart Pharma Private Limited, a active private limited company, was established on 21 January 2016 in Bangalore, Karnataka, India. Engaging in wholesale within the trading sector, it holds CIN: U24233KA2016PTC085427. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Gopavarapu Pavankumar (Director), Segu Srilakshmi (Additional Director). Past directors included Srinivasa Rao Malepati, Gopavarapu Pavankumar, Jayasri Busetty. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.8 Sonnathamanahalli 2Nd Main, 2Nd Cross R.M Nagar, Bangalore, Karnataka, 560036.
U24233KA2016PTC085427
085427
21 January 2016
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Epikart Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gopavarapu Pavankumar | Director | 22 Jan 2016 | Current |
| Segu Srilakshmi | Additional Director | 24 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Director | 24 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epikart Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 22.63% decrease. The company also saw a substantial fall in profitability, with a 65.02% decrease in profit. The company's net worth Soared by an impressive increase of 49.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Epikart Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Epikart Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Epikart Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epikart Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Epikart Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Epikart Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Segu Srilakshmi was appointed as a Additional Director was appointed as a Additional Director on 24 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
Progress on Gopavarapu Pavankumar was appointed as a Director was appointed as a Director on 22 Jan 2016 & has been associated with this company since 9 years 10 months . was documented.
Progress on Epikart Pharma Private Limited was registered on 21 Jan 2016 with Roc Bangalore & aged 9 years 10 months as per MCA records. was documented.
The CIN of Epikart Pharma Private Limited is U24233KA2016PTC085427.
Epikart Pharma Private Limited is headquartered at No.8 Sonnathamanahalli 2Nd Main, 2Nd Cross R.M Nagar, Bangalore, Karnataka, 560036.
Epikart Pharma Private Limited was incorporated on 21 January 2016.
The current directors of Epikart Pharma Private Limited are
The primary industry of Epikart Pharma Private Limited is Trading.
Epikart Pharma Private Limited is unlisted.
The authorized capital of Epikart Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Epikart Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX